Dr. Slichenmyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
121 Bogastow Brook Rd
Sherborn, MA 01770Phone+1 508-650-3403
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1991 - 1994
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1987 - 1990
- University of New Mexico School of MedicineResidency, Pathology-Anatomic and Clinical, 1984 - 1986
- Case Western Reserve University School of MedicineClass of 1984
Certifications & Licensure
- CT State Medical License 2004 - 2024
- MD State Medical License 1991 - 2017
Publications & Presentations
PubMed
- 17 citationsEffects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor.Monette M. Cotreau, Nicholas M. Siebers, James Miller, Strahs Andrew, William Slichenmyer
Clinical Pharmacology in Drug Development. 2015-03-01 - 5 citationsThe effect of food on the pharmacokinetics of tivozanib hydrochloride.Monette M. Cotreau, Lisa Massmanian, Strahs Andrew, William Slichenmyer, Dennis L. Vargo
Clinical Pharmacology in Drug Development. 2014-03-01 - 21 citationsPhase Ib study of tivozanib (AV-951) in combination with temsirolimus in patients with renal cell carcinoma.Mayer Fishman, Sandy Srinivas, Ralph J. Hauke, Robert J. Amato, Brooke Esteves
European Journal of Cancer. 2013-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: